EMA — authorised 31 May 2013
- Application: EMEA/H/C/002597
- Marketing authorisation holder: Arena Pharmaceutical Enterprises Limited
- Local brand name: Belviq
- Indication: As an adjunct to diet and exercise for weight control
- Status: withdrawn
🇪🇺 Lorcaserin, 20 mg in European Union
EMA authorised Lorcaserin, 20 mg on 31 May 2013
Marketing authorisation
Frequently asked questions
Is Lorcaserin, 20 mg approved in European Union?
Yes. EMA authorised it on 31 May 2013.
Who is the marketing authorisation holder for Lorcaserin, 20 mg in European Union?
Arena Pharmaceutical Enterprises Limited holds the EU marketing authorisation.